Researchers led by Wake Forest University School of Medicine and Atrium Health have judged the certainty of evidence on behavioral therapies for irritable bowel syndrome to be low to very low as many published trials show publication bias and methodological risk of bias.
This article was originally published on MedicalXpress.com